Healthcare organizations must better incorporate change management and cultural integration into their M&A strategy. Here's how.
If most patients are not going to exceed their deductible in a given year, they are now “consumers” and are looking for differentiators that offer fixed fee care.
FDA’s approval of the first generic version of Copaxone for treating patients with relapsing forms of multiple sclerosis has industry insiders contemplating the impact on the generics market as well as payer coverage strategies.
The revocation of Blue Shield of California's tax-exempt status raises the question of whether for-profits have a competitive advantage.
Spurred on by the Affordable Care Act, retailers, health plans and providers are staking strong retail positions that are increasing coverage opportunities and access to care.
A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act, premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
2014 was a good year for health insurers, but there are issues in 2015 that could dramatically disrupt the industry’s recent smooth ride.